(25th May 2021) Drug resistance in cancer therapy is one of the grand challenges facing doctors and scientists in modern medicine. According to a study published today in Cell Reports, researchers at Systems Biology Ireland (SBI) have been working to predict and combat these resistances, developing a way to accurately identify biological network context and drug-target interactions that pertain to drug resistance.
In the paper titled A systematic analysis of signalling reactivation and drug resistance the SBI researchers dispel the myths about the development of drug resistances and, through experimental validation, show ways to overcome emerging resistances. The team used a systems theory, modular response analysis (MRA) and mechanistic modelling of signalling pathways to systematically investigate and quantify the changing responses of a cell’s networks related to drug interference.
The paper addresses the known research around targeted therapy, currently one of the most innovative and most specific ways to treat cancer. However, while targeted drugs often provide striking results initially, resistance inevitably occurs and cancer cells no longer die in response to this therapy.
Prof Boris Kholodenko, corresponding author of the study and Deputy Director, SBI, said of the study ‘Our work systematically analyses mechanisms of the emergence of resistance to targeted therapy. We proved that feedback loops cannot fully restore signaling activity that existed before, contrary to general belief in the field. It is signaling network architecture and enzyme dimerization that result in drug resistance and we show how to mitigate that.’
‘In the paper, we analyzed how to overcome these drug resistances using a combination of different drugs to kill cancer cells’ continued Prof Kholodenko.
Ultimately, this means that the researchers found that using these new methods and studying the networks and corresponding drug resistances gives a more comprehensive understanding of how to develop new and better drug combinations. The insights demonstrated in this study could be the next vital step in overcoming drug resistance in the long term.
# # # #
Media Contact
Maryann Kelly
Systems Biology Ireland
T +353 1 716 6331
Notes to editor:
A systematic analysis of signaling reactivation and drug resistance
Cell Reports 2021 https://doi.org/10.1016/j.celrep.2021.109157
The article is available on the Journal website.
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to Cell Press’s open access policy.
2. Cell Reports is an open-access journal from Cell Press that publishes high-quality papers across the entire life sciences spectrum. The primary criterion for publication in Cell Reports, as for all Cell Press journals, is new biological insight. Cell Reports publishes thought-provoking, cutting-edge research, with a focus on a shorter, single-point story, called a Report, in addition to a longer Article format. Cell Reports also publishes Resources, which highlight significant technical advances and/or major informational data sets.
The professional in-house editors of Cell Reports work closely with authors, reviewers, and the journal's scientific editorial board. The editorial board comprises future leaders in their respective fields who guide the journal with regard to its scope, the types of content it publishes, and of course, the quality of the papers it publishes. However, editorial decisions at Cell Reports are made independently by its in-house editors.